FDA's Warning on Ixchiq Vaccine for Chikungunya

The FDA and CDC have recommended pausing the use of the Ixchiq vaccine for chikungunya in adults over 60 due to fatal complications. The vaccine, approved for those aged 18 and older, has caused serious adverse events, including deaths, in older adults.

Study on Adverse Events Linked to Mifepristone (Abortion Pill)

Study reveals serious adverse events linked to mifepristone, also known as the 'abortion pill', with rates 22 times higher than FDA-approved label. Researchers call for reinstating safety protections. Various experts provide contrasting views on the study's findings.